Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Dr. Ume Ruqia Tulain| Pharmaceutics |Assistant Professor at University of Sargodha , Pakistan

Dr. Ume Ruqia Tulain is an Assistant Professor at the Faculty of Pharmacy, University of Sargodha, Pakistan. With over 15 years of teaching and research experience, she specializes in pharmaceutics, focusing on controlled drug delivery systems. She holds a PhD in Pharmaceutics from The Islamia University of Bahawalpur. Dr. Tulain has published numerous papers in renowned international journals, and her research is recognized globally for its contributions to drug delivery technologies. She has actively participated in multiple national and international conferences, workshops, and seminars, contributing significantly to the pharmaceutical sciences community.

Professional Profile

Google Scholar

Scopus

Education

Dr. Ume Ruqia Tulain earned her B-Pharm, M.Phil, and PhD degrees from The Islamia University of Bahawalpur, Pakistan, completing her education with top distinctions. She completed her Matriculation and F.Sc from BISE Sargodha, achieving first divisions. Her academic journey reflects a strong foundation in pharmacy and a commitment to advancing the field of pharmaceutics.

Experience

Dr. Tulain has been an integral part of the Faculty of Pharmacy at the University of Sargodha since 2008, where she has held the roles of Lecturer and Assistant Professor. She has taught a wide array of subjects including Pharmaceutical Quality Management, Dosage Form Design, and Pharmaceutical Microbiology to both undergraduate and postgraduate students. Dr. Tulain also supervises M.Phil and PhD students and has served as an external examiner and reviewer for several international journals. She has been involved in various administrative committees at the university level as well.

Research Interests

Dr. Tulain’s research focuses on the development of controlled drug delivery systems using graft copolymers, hydrogels, microspheres, and nanoparticles as drug carriers. Her work is aimed at improving the efficacy and safety of pharmaceutical formulations. She has conducted significant research in oral controlled drug delivery and formulation development, with a special interest in the in vitro and in vivo evaluation of novel drug carriers.

Awards

Dr. Tulain has received multiple awards for her outstanding research contributions. In 2022 and 2023, she was honored with the “Research Award in recognition of outstanding research publication” for her prolific work in pharmaceutical sciences. Additionally, her research projects have garnered attention, including the successful co-investigation of a project on controlled drug delivery systems. She was also a recipient of the “Best Researcher” award at the University of Sargodha.

Publications

Nigella sativa (Prophetic Medicine): A Review

Citations: 131

Lactic acid bacteria in traditional fermented Asian foods

Citations: 78

Preparation and characterization of pH sensitive crosslinked Linseed polysaccharides-co-acrylic acid/methacrylic acid hydrogels for controlled delivery of ketoprofen

Citations: 51

Fabrication of Ph‐responsive hydrogel and its in vitro and in vivo evaluation

Citations: 50

β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation

Citations: 42

Acute toxicity studies of a novel excipient arabinoxylan isolated from Ispaghula (Plantago ovata) husk

Citations: 39

Thiolation of arabinoxylan and its application in the fabrication of pH-sensitive thiolated arabinoxylan grafted acrylic acid copolymer

Citations: 35

Design and in vitro evaluation of pH-sensitive crosslinked chitosan-grafted acrylic acid copolymer (CS-co-AA) for targeted drug delivery

Citations: 33

pH sensitive pluronic acid/agarose-hydrogels as controlled drug delivery carriers: design, characterization and toxicity evaluation

Citations: 26

Microwave radiation induced synthesis of hydroxypropyl methylcellulose-graft-(polyvinylalcohal-co-acrylic acid) polymeric network and its in vitro evaluation

Citations: 24

 

Conclusion

Dr. Tulain’s exceptional research output, coupled with her commitment to advancing pharmaceutical sciences and fostering academic excellence, positions her as an outstanding candidate for the “Best Researcher Award.” Her consistent contributions, coupled with her leadership in the research community, make her an excellent role model and deserving of this recognition.

Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Assist Prof. Dr.Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Assistant Professor at Future University in Egypt

Dr. Shymaa Hatem Abdel-Azeem is a distinguished academic and researcher in the field of pharmaceutics and pharmaceutical technology. She currently serves as a Lecturer at the Faculty of Pharmacy, Future University in Egypt. With over a decade of academic experience, she has contributed significantly to pharmaceutical research, focusing on advanced drug delivery systems and nanotechnology-based therapies for dermatological conditions. Dr. Shymaa is recognized for her leadership in various academic and professional organizations, contributing to the advancement of pharmaceutical sciences and women’s empowerment in the Arab world.

Profile:

Google Scholar

Education:

Dr. Shymaa earned her Ph.D. in Pharmaceutical Sciences (Pharmaceutical Technology) from Ain Shams University in June 2022. Her doctoral research focused on the “Preparation and Evaluation of Topical Nanoformulations for the Treatment of Melasma.” She holds an M.Sc. in Pharmaceutical Sciences (Pharmaceutics) from Ain Shams University, completed in 2018, where her thesis examined “Preparation and Characterization of Topical Antioxidant Formulations.” In 2010, she graduated with a B.Sc. in Pharmaceutical Sciences and Pharmaceutical Industries from Cairo University, achieving an overall grade of “Excellent.”

Experience:

Dr. Shymaa has been a key academic figure at Future University in Egypt since 2012. Starting as a Teaching Assistant in the Department of Pharmaceutics and Pharmaceutical Technology, she progressed to Assistant Lecturer and eventually to her current position as Lecturer. She is also a member of the Consulting Staff at several organizations, including the International Arab-African Council for Diplomatic Relations and Peace between Nations, and the Egyptian Association of Continuing Medical Education Development. In 2023, she was certified as an expert in Arabic women’s issues by the International Leadership Center.

Research Interest:

Dr. Shymaa’s research interests are centered around the development of innovative drug delivery systems, with a special focus on nanotechnology. Her work emphasizes the formulation of topical treatments for dermatological conditions such as melasma, psoriasis, and acne. She also explores the application of nanostructured lipid carriers and vesicular systems for the enhanced delivery of active pharmaceutical ingredients to the skin and brain. Her goal is to enhance the clinical efficacy of drugs using novel pharmaceutical technologies.

Awards:

Throughout her career, Dr. Shymaa has earned recognition for her contributions to the field of pharmaceutical sciences. In 2024, she completed the Training of Trainers (TOT) program from Ain Shams University, which certified her as a professional trainer. Her leadership and active participation in community services, particularly in women’s empowerment, have also been acknowledged by various professional organizations.

Publications:

Dr. Shymaa has published extensively in high-impact journals, with her research widely cited within the scientific community. Below are selected publications, complete with links and journal details:

“Clinical Cosmeceutical Repurposing of Melatonin in Androgenic Alopecia Using Nanostructured Lipid Carriers Prepared with Antioxidant Oils” (2018). Published in Expert Opinion on Drug Delivery and cited by 62 articles. Link to paper.

“Melatonin Vitamin C-based Nanovesicles for Treatment of Androgenic Alopecia: Design, Characterization, and Clinical Appraisal” (2018). Published in European Journal of Pharmaceutical Sciences and cited by 48 articles. Link to paper.

“Recent Advances in Antioxidant Cosmeceutical Topical Delivery” (2018). Published in Current Drug Delivery and cited by 36 articles. Link to paper.

“Background and Different Treatment Modalities for Melasma: Conventional and Nanotechnology-Based Approaches” (2020). Published in Journal of Drug Delivery Science and Technology and cited by 25 articles. Link to paper.

“Functionalized Chitosan Nanoparticles for Cutaneous Delivery of a Skin Whitening Agent: An Approach to Clinically Augment the Therapeutic Efficacy for Melasma Treatment” (2022). Published in Drug Delivery and cited by 14 articles. Link to paper.

“Optimization of the Colloidal Properties of Chitosan Nanoparticles Encapsulating Alpha-Arbutin” (2022). Published in Archives of Pharmaceutical Sciences Ain Shams University and cited by 8 articles. Link to paper.

“Novel Anti-Psoriatic Nanostructured Lipid Carriers for the Cutaneous Delivery of Luteolin: A Comprehensive In-Vitro and In-Vivo Evaluation” (2023). Published in European Journal of Pharmaceutical Sciences and cited by 5 articles. Link to paper.

Conclusion:

Shymaa Hatem Abdel-Azeem is a highly competent researcher with notable achievements in pharmaceutical nanotechnology and drug delivery systems. Her leadership roles and academic contributions, especially to women’s issues in the Arab world, underscore her qualifications for the “Research for Women Researcher Award.” By continuing to grow her international collaborations, expanding her research focus, and securing further funding, she can further solidify her standing as an influential figure in her field.